Data Sources
The public registries, study records, and supporting materials that inform Second Look Cancer content and trial pages.
Primary source material
The platform relies heavily on public clinical trial registry data, especially ClinicalTrials.gov, together with sponsor- and site-level materials when they are publicly accessible.
Registry records remain the primary source for identifiers, statuses, locations, and official study descriptions.
Why more than one source may be referenced
Patients often need more context than a single record provides, especially when trying to understand plain-language fit, logistics, or treatment framing.
Where appropriate, supplementary public materials may help clarify what a study is testing or how it is being positioned.
How to use the information
Patients should treat Second Look Cancer as a decision-support layer, not as the final authority on enrollment.
The source record, study site, and oncology team should always be used to confirm practical next steps.